1019918-39-8

Basic information

• Product Name: 4-BroMo-2-hydrazinylpyridine
• Synonyms: (4-Bromo-pyridin-2-yl)-hydrazine;4-BroMo-2-hydrazinylpyridine;4-Bromo-2-hydrazinopyridine;Pyridine, 4-bromo-2-hydrazinyl-
• CAS NO: 1019918-39-8
• Molecular Formula: C₅H₆BrN₃
• Molecular Weight: 188.02524
• Mol File: 1019918-39-8.mol
• Article Data: 13

Chemical Properties

• Appearance: /
• Storage Temp.: Keep in dark place,Inert atmosphere,Store in freezer, under -20°C
• CAS DataBase Reference: 4-BroMo-2-hydrazinylpyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 4-BroMo-2-hydrazinylpyridine(1019918-39-8)
• EPA Substance Registry System: 4-BroMo-2-hydrazinylpyridine(1019918-39-8)

Safety Data

• Hazardous Substances Data: 1019918-39-8(Hazardous Substances Data)

Usage

General Description

4-Bromo-2-hydrazinylpyridine is an organic compound with the chemical formula C5H6BrN3. It is a pyridine derivative with a bromine atom and a hydrazine functional group attached to the pyridine ring. 4-Bromo-2-hydrazinylpyridine has been studied for its potential use in organic synthesis and drug development. It possesses interesting properties and has shown promise in various chemical reactions and biological activities. Its structure and reactivity make it a valuable building block for the synthesis of complex organic molecules and pharmaceutical compounds. Further research on 4-Bromo-2-hydrazinylpyridine could provide new insights into its potential applications in the field of chemistry and medicine.

Upstream product

• 128071-98-7 4-bromo-2-fluoropyridine 

Downstream Products

• 1019918-63-8 1-(4-bromopyridin-2-yl)-4-isopropylsemicarbazide 
• 1019918-47-8 7-Bromo-3-(2-chlorophenyl)-[1,2,4]triazolo[4,3-a]pyridine 
• 1190927-76-4 7-bromo-3-methyl-[1,2,4]triazolo[4,3-a]pyridine 
• 832735-60-1 7-bromo-[1,2,4]triazolo[4,3-a]pyridine 

Relevant articles and documents

GPR52 MODULATOR COMPOUNDS

The disclosures herein relate to novel compounds of Formula (1): and salts thereof, wherein X, Y, R1, R2, R3 and R4 are defined herein, and their use in treating, preventing, ameliorating, controlling or reducing the risk of disorders associated with GPR52 receptors.

INHIBITORS OF KEAP1-Nrf2 PROTEIN-PROTEIN INTERACTION

Sultam compounds, pharmaceutical compositions containing them, methods of making them, and methods of using them including methods for treating disease states, disorders, and conditions associated with the KEAP1-Nrf2 interaction, such as inflammatory bowel disease, including Crohn's disease and ulcerative colitis.

SUBSTITUTED HETEROARYL COMPOUNDS AND METHODS OF USE

The present invention provides novel heteroaryl compounds, pharmaceutical acceptable salts and formulations thereof. They are useful in preventing, managing, treating or lessening the severity of a protein kinase-mediated disease. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of protein kinase-mediated disease.